TY - JOUR
T1 - PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
AU - Lin, A.
AU - Chang, J.H.C.
AU - Grover, R.S.
AU - Hoebers, F.J.P.
AU - Parvathaneni, U.
AU - Patel, S.H.
AU - Thariat, J.
AU - Thomson, D.J.
AU - Langendijk, J.A.
AU - Frank, S.J.
AU - International Particle Therapy Co-operative Group (PTCOG)
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.Methods: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.Results: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.Conclusion: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.
AB - Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.Methods: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.Results: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.Conclusion: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.
KW - head and neck cancer
KW - proton therapy
KW - INTENSITY-MODULATED RADIOTHERAPY
KW - PROTON-BEAM THERAPY
KW - LOCALLY ADVANCED HEAD
KW - 2ND PRIMARY HEAD
KW - QUALITY-OF-LIFE
KW - RADIATION-THERAPY
KW - HUMAN-PAPILLOMAVIRUS
KW - NASOPHARYNGEAL CARCINOMA
KW - MULTIFIELD OPTIMIZATION
KW - OROPHARYNGEAL CANCER
U2 - 10.14338/IJPT-20-00071.1
DO - 10.14338/IJPT-20-00071.1
M3 - Article
C2 - 34285938
SN - 2331-5180
VL - 8
SP - 84
EP - 94
JO - International Journal of Particle Therapy
JF - International Journal of Particle Therapy
IS - 1
ER -